Coverage

The U.S. Food and Drug Administration (FDA) hearing on July 23 to collect feedback on the clinical use and safety concerns associated with prescription fluoride supplements for kids revealed supporters and opponents, but the writing may be on the wall…
“We’ve got to look at a risk-benefit analysis. And since this isn’t approved, it’s never been through the rigorous FDA process of saying there’s a benefit that outweighs the risk,” Tidmarsh told NOTUS about the fluoride supplements. “And if there’s not…
The Food and Drug Administration (FDA) said it plans to ban fluoride tablets and drops, which have long been prescribed to children in areas where the mineral is not added to drinking water. On Wednesday, July 23, the agency will hold a public meeting…
Dr. James H. Bekker made it clear while standing at a podium in front of the U.S. Food and Drug Administration (FDA) in Silver Spring, Md. on July 23: there is no way to replace fluoride supplements if the government decides to take them off the market.
A meeting Wednesday at the Food and Drug Administration about fluoride supplements became, at one point, a contentious back-and-forth over whether the ingestible tablets harm children’s microbiomes or play a vital role in helping protect them from tooth…
On Wednesday, the Food and Drug Administration will host a public meeting featuring both supporters and opponents of fluoride supplements. While dentists overwhelmingly say the tablets have been used safely for decades, more than half of the meeting…
A public meeting hosted by the Reagan-Udall Foundation will take place July 23 at the FDA’s White Oak Campus in Silver Spring, Maryland. The meeting will explore the safety of prescription fluoride supplements, with discussions focused on…
The U.S. Food and Drug Administration (FDA) is preparing to evaluate the continued availability of ingestible fluoride supplements, including tablets and drops commonly prescribed to children in areas lacking fluoridated water.
FDA Commissioner Marty Makary touted the agency’s first 100 days under the new Trump administration during an event Thursday, emphasizing efforts to ramp up hiring and divert resources to food research, Amanda reports.
New developments in the field of biomedicine, including new genomic and cellular therapies, present tremendous opportunities for their applications to animal health, welfare and food production, as documented in FDA-CVM’s Animal and Veterinary Industry…